Cardiovascular & Respiratory Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- 2 year (est.)
- Value
- £1K-£96M
- Sector
- HEALTH
- Published
- 07 Apr 2021
- Delivery
- To 12 Apr 2023 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Geochart for 1 buyers and 82 suppliers
1 buyer
- NHS National Services Scotland Edinburgh
43 suppliers
- Mercury Pharma Group Croydon
- Glaxosmithkline Brentford
- Martindale Pharma Romford
- Mylan Hatfield
- DR Reddys Laboratories Beverley
- Accord Healthcare North Harrow
- Chiesi Manchester
- Ennogen Healthcare Dartford
- Teva Castleford
- Thornton & Ross Huddersfield
- Aventis Pharma Reading
- Napp Pharmaceuticals Cambridge
- Zentiva Pharma London
- Aspire Pharma Petersfield
- Cipla Eu Addlestone
- Firstline Pharma Hemel Hempstead
- Glenmark Pharmaceuticals Europe Watford
- Sandoz Camberley
- Selective Supplies Haywards Heath
- Colonis Pharma Burnopfield
- Aguettant Bristol
- Baxter Healthcare Berkshire
- Bowmed Ibisqus Wrexham
- Consilient Health Richmond
- Correvio Bielefeld
- Crescent Pharma Basingstoke
- Brown & Burk West London
- Focus Pharmaceuticals Burton upon Trent
- Galen Craigavon
- Hameln Pharmaceuticals Gloucester
- Intrapharm Laboratories Maidenhead
- Kent Pharmaceuticals Ashford
- Morningside Pharmaceuticals Leicestershire
- Norgine Pharmaceuticals Uxbridge
- Organon Pharmaceutical Hertfordshire
- Pfizer Tadworth
- Ranbaxy London
- Rosemont Pharmaceuticals Leeds
- Sintetica London
- Synchrony Pharma Stevenage
- Syri London
- Torrent Pharma Crawley
- Wockhardt Wrexham
Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into fifteen (15) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 1 | Epoprostenol powder and solvent (pH10.5) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority has awarded all products within this lot to a single supplier. Award Criteria
| ||||
| 2 | Epoprostenol powder and solvent (pH12) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Award Criteria
| ||||
| 3 | Epinephrine (Adrenaline) Pre-filled syringes Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier. Award Criteria
| ||||
| 4 | Epinephrine (Adrenaline) Auto Injector Devices Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier. Award Criteria
| ||||
| 5 | Fondaparinux Sodium Pre-filled Syringes Supply of Fondaparinux Sodium Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework Participants. Award Criteria
| ||||
| 7 | Isosorbide Mononitrate Modified Release Capsules and Tablets Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants. Award Criteria
| ||||
| 8 | Diltiazem Hydrochloride Modified Release Capsules and Tablets Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants. Award Criteria
| ||||
| 9 | Verapamil Hydrochloride Modified Release Capsules and Tablets Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier. Award Criteria
| ||||
| 10 | Nifedipine Modified Release Capsules and Tablets Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to three (3) Framework Participants. Award Criteria
| ||||
| 11 | Theophylline Modified Release Capsules and Tablets Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier. Award Criteria
| ||||
| 12 | Branded and Branded Generic Inhalers Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants. Award Criteria
| ||||
| 13 | Bosentan Tablets Supply of Bosentan Tablets to NHS Scotland. The Authority has awarded this Lot as a multi-supplier unranked framework to five (5) Framework Participants. Award Criteria
| ||||
| 14 | Iloprost Medicines Supply of Iloprost Solutions for Infusion and Nebuliser solutions, to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi supplier unranked framework agreement on a line by line basis to three (3) suppliers. Award Criteria
| ||||
| 15 | All other Cardiovascular & Respiratory Medicines Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. The Authority has awarded each line within this lot to a single supplier. Award Criteria
|
Award Detail
| 1 | Mercury Pharma Group (Croydon)
|
| 2 | Glaxosmithkline (Brentford)
|
| 3 | Martindale Pharma (Romford)
|
| 4 | Mylan (Hatfield)
|
| 5 | DR Reddys Laboratories (Beverley)
|
| 6 | Mylan (Hatfield)
|
| 7 | Accord Healthcare (North Harrow)
|
| 8 | Chiesi (Manchester)
|
| 9 | Ennogen Healthcare (Dartford)
|
| 10 | Martindale Pharma (Romford)
|
| 11 | Mercury Pharma Group (Croydon)
|
| 12 | Teva (Castleford)
|
| 13 | Thornton & Ross (Huddersfield)
|
| 14 | Aventis Pharma (Reading)
|
| 15 | Ennogen Healthcare (Dartford)
|
| 16 | Martindale Pharma (Romford)
|
| 17 | Napp Pharmaceuticals (Cambridge)
|
| 18 | Thornton & Ross (Huddersfield)
|
| 19 | Zentiva Pharma (London)
|
| 20 | Mylan (Hatfield)
|
| 21 | Ennogen Healthcare (Dartford)
|
| 22 | Thornton & Ross (Huddersfield)
|
| 23 | Zentiva Pharma (London)
|
| 24 | Napp Pharmaceuticals (Cambridge)
|
| 25 | Aspire Pharma (Petersfield)
|
| 26 | Chiesi (Manchester)
|
| 27 | Cipla Eu (Addlestone)
|
| 28 | Ennogen Healthcare (Dartford)
|
| 29 | Firstline Pharma (Hemel Hempstead)
|
| 30 | Glaxosmithkline (Brentford)
|
| 31 | Glenmark Pharmaceuticals Europe (Watford)
|
| 32 | Mylan (Hatfield)
|
| 33 | Sandoz (Camberley)
|
| 34 | Selective Supplies (Haywards Heath)
|
| 35 | Teva (Castleford)
|
| 36 | Thornton & Ross (Huddersfield)
|
| 37 | Accord Healthcare (North Harrow)
|
| 38 | Cipla Eu (Addlestone)
|
| 39 | Mercury Pharma Group (Croydon)
|
| 40 | Mylan (Hatfield)
|
| 41 | Zentiva Pharma (London)
|
| 42 | Colonis Pharma (Burnopfield)
|
| 43 | Zentiva Pharma (London)
|
| 44 | Firstline Pharma (Hemel Hempstead)
|
| 45 | Accord Healthcare (North Harrow)
|
| 46 | Aguettant (Bristol)
|
| 47 | Aspire Pharma (Petersfield)
|
| 48 | Aventis Pharma (Reading)
|
| 49 | Baxter Healthcare (Berkshire)
|
| 50 | Bowmed Ibisqus (Wrexham)
|
| 51 | Chiesi (Manchester)
|
| 52 | Cipla Eu (Addlestone)
|
| 53 | Consilient Health (Richmond)
|
| 54 | Correvio (Bielefeld)
|
| 55 | Crescent Pharma (Basingstoke)
|
| 56 | Ennogen Healthcare (Dartford)
|
| 57 | Brown & Burk (West London)
|
| 58 | Focus Pharmaceuticals (Burton upon Trent)
|
| 59 | Galen (Craigavon)
|
| 60 | Glenmark Pharmaceuticals Europe (Watford)
|
| 61 | Hameln Pharmaceuticals (Gloucester)
|
| 62 | Intrapharm Laboratories (Maidenhead)
|
| 63 | Kent Pharmaceuticals (Ashford)
|
| 64 | Martindale Pharma (Romford)
|
| 65 | Mercury Pharma Group (Croydon)
|
| 66 | Morningside Pharmaceuticals (Leicestershire)
|
| 67 | Mylan (Hatfield)
|
| 68 | Norgine Pharmaceuticals (Uxbridge)
|
| 69 | Organon Pharmaceutical (Hertfordshire)
|
| 70 | Pfizer (Tadworth)
|
| 71 | Ranbaxy (London)
|
| 72 | Rosemont Pharmaceuticals (Leeds)
|
| 73 | Sandoz (Camberley)
|
| 74 | Selective Supplies (Haywards Heath)
|
| 75 | Sintetica (London)
|
| 76 | Synchrony Pharma (Stevenage)
|
| 77 | Syri (London)
|
| 78 | Teva (Castleford)
|
| 79 | Thornton & Ross (Huddersfield)
|
| 80 | Torrent Pharma (Crawley)
|
| 81 | Wockhardt (Wrexham)
|
| 82 | Zentiva Pharma (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated values referred to in Section II.I.7 and all Lots cover the twenty-four (24) months contract duration and the twelve (12) month extension period of the framework agreement. Full details are available on request from the Authority for all awarded products within each Lot. (SC Ref:645807)
Reference
- ocds-h6vhtk-02a300
- FTS 007055-2021